LPL Financial
MTNB icon

LPL Financial’s Matinas BioPharma MTNB Stock Holding History

LPL Financial’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-12,247
Closed -$96.9K – 5253
2024
Q2 		$96.9K Hold
12,247
– – ﹤0.01% 4750
2024
Q1 		$166K Sell
12,247
-24
-0.2% -$285 ﹤0.01% 4545
2023
Q4 		$133K Sell
12,271
-80
-0.6% -$903 ﹤0.01% 4498
2023
Q3 		$80.3K Sell
12,351
-60
-0.5% -$737 ﹤0.01% 4457
2023
Q2 		$223K Sell
12,411
-288
-2% -$6.71K ﹤0.01% 4075
2023
Q1 		$298K Hold
12,699
– – ﹤0.01% 3747
2022
Q4 		$317K Buy
12,699
+300
+2% +$9.98K ﹤0.01% 3605
2022
Q3 		$394K Buy
12,399
+7,099
+134% +$279K ﹤0.01% 3361
2022
Q2 		$209K Sell
5,300
-16
-0.3% -$610 ﹤0.01% 3914
2022
Q1 		$214K Sell
5,316
-238
-4% -$8.76K ﹤0.01% 3799
2021
Q4 		$280K Hold
5,554
– – ﹤0.01% 3728
2021
Q3 		$361K Buy
5,554
+2,435
+78% +$105K ﹤0.01% 3497
2021
Q2 		$121K Buy
3,119
+63
+2% +$2.71K ﹤0.01% 4027
2021
Q1 		$160K Buy
3,056
+366
+14% +$24.6K ﹤0.01% 3834
2020
Q4 		$183K Buy
+2,690
New +$125K ﹤0.01% 3554

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

LPL Financial's MTNB Position: Q3 2024 in Review

LPL Financial sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 12,247 shares — an estimated $96.9K sold.

LPL Financial first reported a position in MTNB in Q4 2020 and held it in 15 quarters. The position peaked at $394K in Q3 2022. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • LPL Financial reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • LPL Financial sold 12,247 Matinas BioPharma shares in Q3 2024, an estimated $96.9K.
  • LPL Financial first reported a position in Matinas BioPharma in Q4 2020 and held it in 15 quarters.
  • LPL Financial's Matinas BioPharma position peaked at $394K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on LPL Financial's 13F filing for Q3 2024, filed 8 Nov 2024.